Similar articles

• Phorbol ester activates CD5+ leukaemic B cells via a T cell-independent mechanism.

  Tangye SG, Weston KM, Raison RL. Tangye SG, et al. Immunol Cell Biol. 1995 Feb;73(1):44-51. doi: 10.1038/icb.1995.7. Immunol Cell Biol. 1995. PMID: 7539402
• Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.

  Teutsch M, Higer M, Wang D, Wortis HW. Teutsch M, et al. Int Immunol. 1995 Mar;7(3):381-92. doi: 10.1093/intimm/7.3.381. Int Immunol. 1995. PMID: 7540861
• Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.

  Tangye SG, Weston KM, Raison RL. Tangye SG, et al. Immunol Cell Biol. 1997 Dec;75(6):561-7. doi: 10.1038/icb.1997.87. Immunol Cell Biol. 1997. PMID: 9492192
• Isotype switching in CD5 B cells.

  Whitmore AC, Haughton G, Arnold LW. Whitmore AC, et al. Ann N Y Acad Sci. 1992 May 4;651:143-51. doi: 10.1111/j.1749-6632.1992.tb24603.x. Ann N Y Acad Sci. 1992. PMID: 1376029 Review. No abstract available.
• Alternative hypotheses of lymphocyte surface immunoglobulin expression, B lymphocyte activation and B lymphocyte differentiation.

  Sell S, Skaletsky E, Holdbrook R, Linthicum DS, Raffel C. Sell S, et al. Immunol Rev. 1980;52:141-79. doi: 10.1111/j.1600-065x.1980.tb00334.x. Immunol Rev. 1980. PMID: 7021395 Review. No abstract available.